Ankylosing Spondylitis News

September 21, 2020September 22, 2020

Obesity Increases Risk of Worse Overall Health in AS

Obesity is a risk factor for worse overall health in people with ankylosing spondylitis (AS), and is associated with increased inflammation, disease activity, and cardiovascular risk, a Taiwanese study has ... Read more

September 14, 2020September 15, 2020

Cosentyx Effective in Active nr-axSpA, Phase 3 PREVENT Trial Shows

Ankylosing Spondylitis News

Treatment with Cosentyx (secukinumab) leads to sustained reductions in symptoms of active non-radiographic axial spondyloarthritis (nr-axSpA) over one year, according to the Phase 3 PREVENT trial. These findings were the ... Read more

September 3, 2020September 3, 2020

Same But Different Photo Contest Celebrates People With Rare Diseases

Ankylosing Spondylitis News

Same But Different, a U.K. nonprofit that uses the arts to bring communities together, is holding a calendar photography competition to raise awareness for rare diseases. Under the theme “A ... Read more

August 31, 2020August 31, 2020

AbbVie Seeks FDA, EMA Approvals of Rinvoq for Active AS

Ankylosing Spondylitis News

AbbVie has submitted an application to the U.S. Food and Drug Administration (FDA) requesting the approval of Rinvoq (upadacitinib) for the treatment of adults with active ankylosing spondylitis (AS). A ... Read more

August 24, 2020August 24, 2020

TNF Inhibitors Significantly Slow Bone Damage in AS

Ankylosing Spondylitis News

Disease progression slowed significantly in people with ankylosing spondylitis (AS) when they were on TNF inhibitors, compared to when they were off the medications, a long-term study has found. This ... Read more

August 20, 2020September 20, 2020

EveryLife Foundation Launches Scholarship Fund for Rare Disease Community in US

Ankylosing Spondylitis News

The EveryLife Foundation for Rare Diseases has launched a scholarship fund in the U.S. to support individuals with rare disorders who are pursuing personal goals through training and education. The ... Read more

August 17, 2020August 18, 2020

IL-17 Inhibitors Can Ease Symptoms But Raise Infection Risk

Ankylosing Spondylitis News

Treatments blocking interleukin (IL)-17A, the so-called IL-17 inhibitors, can effectively ease symptoms in people with ankylosing spondylitis (AS), but also increase the risk of mild to moderate infections, a review study ... Read more

August 12, 2020September 13, 2020

New Streaming Channel Showcases Rare Disease Films

Ankylosing Spondylitis News, COVID-19 News

When the COVID-19 pandemic forced the postponement of a rare disease film festival originally slated for May, its organizers set out to find a new way to bring the films ... Read more

August 10, 2020August 10, 2020

nr-axSpA Given Diagnostic Code on International Classification of Diseases

Ankylosing Spondylitis News

Non-radiographic axial spondyloarthritis (nr-axSpA) has been given a diagnostic code, M46.80, that will be used to identify the condition in the 10th edition of the International Classification of Diseases, Clinical ... Read more

August 3, 2020August 3, 2020

Year’s Use of Cimzia Can Lead to Sustained Remission, Phase 3b Trial Shows

Ankylosing Spondylitis News

Nearly one year of treatment with Cimzia (certolizumab pegol) led to sustained disease remission and a better quality of life in adults with early axial spondyloarthritis (axSpA), according to data ... Read more

July 29, 2020July 29, 2020

EU Approves Under-the-skin Remsima Injectable for 5 Autoimmune Disorders

Ankylosing Spondylitis News, COVID-19 News

An under-the-skin injectable formulation of Remsima (infliximab), called Remsima SC, has been approved in European Union for the treatment of five autoimmune disorders, including ankylosing spondylitis. The approval by the European Commission ... Read more

July 20, 2020July 20, 2020

Mindfulness Linked to Reduced Fatigue-associated Disability in Arthritis

Ankylosing Spondylitis News

On days when they are more mindful or engaged in meaningful activities, people with ankylosing spondylitis or rheumatoid arthritis experience less impairment due to fatigue, a study suggests. The study, ... Read more

July 13, 2020July 13, 2020

Hulio, Humira Biosimilar, Approved But Not Available Until 2023

Ankylosing Spondylitis News

The U.S. Food and Drug Administration (FDA) has approved Hulio, a biosimilar of Humira (adalimumab), to treat chronic inflammatory disorders such as ankylosing spondylitis. However, Hulio (adalimumab-fkjp) — developed by Mylan and Fujifilm Kyowa ... Read more

July 9, 2020August 9, 2020

National Survey Seeks to Assess Full Social, Economic Burdens of Rare Diseases in US

Ankylosing Spondylitis News

The EveryLife Foundation for Rare Diseases has launched a nationwide National Burden of Rare Disease Survey to measure the full implications, economic and social, of living with rare disease in ... Read more

July 6, 2020July 6, 2020

CHMP Favors At-home Injection Form of Remsima for Europe

Ankylosing Spondylitis News, COVID-19 News

The Committee for Medicinal Products for Human Use (CHMP), a branch of the European Medicines Agency (EMA), is recommending the use of a subcutaneous (under the skin) injection formulation of ... Read more